Filter
187
Filtered Results: 187
Text search:
dolutegravir
Featured
Recommendations
22
New Publications
43
Language
Document type
No document type
86
Guidelines
43
Studies & Reports
34
Manuals
9
Strategic & Response Plan
7
Fact sheets
3
Training Material
2
Infographics
2
Situation Updates
1
Countries / Regions
Global
8
South Africa
8
Argentina
7
Malawi
5
Latin America and the Carribbean
5
Kenya
4
Brazil
4
Colombia
3
Africa
3
Namibia
3
Venezuela
2
South–East Asia Region
2
Botswana
2
Myanmar / Burma
2
Nepal
1
Thailand
1
Ukraine
1
Lesotho
1
Chile
1
Nigeria
1
Burkina Faso
1
Peru
1
Zimbabwe
1
Philippines
1
Guinea
1
Mozambique
1
Congo, Democratic Republic of
1
Western Pacific Region
1
Western and Central Europe
1
North America
1
Bolivia
1
Uganda
1
Central African Republic
1
Ethiopia
1
Chad
1
Zambia
1
Somalia
1
Authors & Publishers
Publication Years
Category
Countries
48
Clinical Guidelines
27
Women & Child Health
4
Public Health
2
Pharmacy & Technologies
2
Key Resources
1
Toolboxes
HIV
117
TB
15
Pharmacy
11
COVID-19
4
AMR
4
NTDs
3
Mental Health
2
Refugee
2
Conflict
2
Guidelines
HIV drug resistance
July 2017
HIV i-Base
July 2018
Technical Update
HIV Treatment
July 2017
People living with HIV depend on life-saving antiretroviral therapy (ART) and access to ART must be maintained during periods of travel restrictions and lockdowns resulting from the COVID-19 pandemic. The Information note on HIV and COVID-19 addresses common concerns people living with HIV have rega...
La Profilaxis Post-Exposición para el VIH (PEP) constituye una herramienta de prevención que consiste en el uso de medicamentos antiretrovirales para reducir el riesgo de infección luego de situaciones de potencial exposición del virus. Su incorporación está recomendada por la Organización Mu...
National Guidelines for HIV & AIDS Care and Treatment (5th Edition)
Supplement to the 2016 consolidated Guidelines on the use of antiretroviral drugs for Treating and Preventing HIV infection
HIV Treatment
July 2019
Policy brief
HIV Treatment
Provide guidance to HIV care practitioners on the optimal use of antiretroviral (ARV) agents for the treatment of HIV infection in adults and adolescents.
MSF International AIDS Working Group
Research Article
PLOS ONE | DOI:10.1371/journal.pone.0164619 October 13, 2016
WHO
Considering programmatic implications of rising levels of HIV drug resistance: finalizing the Global Action Plan
Webinars 12 13 Dec 2016
For the global community to be able to achieve ambitious targets relating to the prevention and treatment of HIV, viral hepatitis and sexually transmitted infections (STIs), multiple types of medicines must be widely accessible to all affected populations in all countries.
The purpose of this rep...
The Department of Health (DOH) has developed a National Integrated Sexual and Reproductive Health and Rights (SRHR) Policy.1 This policy addresses the many cross-cutting issues relating to SRH service provision, drawing together the principles, rights, and guidance for planning and implementation th...
